Search Tag: gadolinium-based contrast agents

IMAGING Management

#RSNA18: AI may help reduce MRI gadolinium dose

2018 27 Nov

In a study presented at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, researchers using artificial intelligence have developed a deep learning algorithm that may lead to the reduction of the gadolinium dose used in contrast material for MRI exams. “There is concrete evidence that gadolinium deposits in the brain... Read more

IMAGING Management

Study: Gadolinium Deposition in Brain Tissues 'More Widespread'

2017 27 Jun

Minute traces of gadolinium, the contrast agent used to enhance MR images, are often retained in the brain tissue of patients years after undergoing MRI. New research suggests however that gadolinium retention may be more widespread and may be present in many more, or possibly all, patients exposed to gadolinium-based contrast agents. The findings,... Read more